“Along with growth, we are seeing good operating margin expansion and are tracking ahead of the approximately 25% margin rate by 2027.”

In context

“plies second half organic sales growth of high-3s or better over 2x macro and margin expansion of about 100 basis points from the prior year resulting in EPS growth of approximately $0.30 at the midpoint. Sequentially, we expect operating profit to follow typical seasonality with similar phasing between the halves while earnings will see an impact from tax timing. Turning to Slide 10, I want to take a minute to highlight the progress we have made since our Investor Day last year. We are at the halfway point with the strong 2025 foundation and the updated 2026 guidance, we are tracking ahead of Investor Day commitments across all metrics. Our growth trajectory continues to accelerate from commercial excellence and innovation, and is on track to exceed the $1 billion above macro commitment. Along with growth, we are seeing good operating margin expansion and are tracking ahead of the approximately 25% margin rate by 2027. For earnings, we are trending to a double digit CAGR reflecting strong operational improvements coupled with below the line efficiency. And on cash, we expect to continue the strong trajectory exceeding our cumulative cash commitment and $10 billion return to shareholders. Overall, we are pleased with the progress we are making and want to thank the team for their relentless focus determined pace, and strong execution to drive long term value for our shareholders. With that, let's open the call for questions. Operator: If you are using a speakerphone, please lift up on your handset before entering Our first question comes from the line of Jeffrey Sprague with Vertical Research. Please proceed with your question. Jeff Sprague: Nigel to see the top line here. Bill, I was wondering if you co”